• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCSB API Products

API Products

Announcements
Financial
Annual Reports
Shareholders Services

Announcements

Home > Investor Relations >Announcements
2026/03/05 The board of directors resolved to handle private placement of domestic convertible corporate bonds (including secured or unsecured ).
2026/03/05 The board of directors resolved to conduct private placement of ordinary shares
2026/03/05 To announce the termination of private security offering approved by 2025 shareholders' meeting
2026/03/05 The Board of Directors resolved not to distribute dividends of 2025
2026/03/05 The Board of Directors approved the consolidated financial reports of 2025
2026/03/05 Resolution of the Board of Directors for convening the 2026 Annual General Shareholders' Meeting
2026/02/25 Announcement for the expected date of the Board of Directors Meeting for 2025 Consolidated Financial Statements is 2026/03/05
2025/12/23 The Company's Board of Directors approved the renaming of the “Compensation Committee” to “Compensation and Nomination Committee”.
2025/11/11 Announce the company's 2025Q3 consolidated financial reports approved by the board of directors
2025/11/04 Announcement for the expected date of the Board of Directors Meeting for 2025 Third Quarter consolidatedfinancial statements is 2025/11/11
   1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.